LAVIPHARM S.A. NA EO 1 (BXA0) — Financial Flexibility Index
LAVIPHARM S.A. NA EO 1 (BXA0) has a Financial Flexibility Index of 0.20x as of December 2024. Free cash flow of €14.28 Million (operating CF €4.64 Million minus capex €9.64 Million) represents 0% of total liabilities (€72.52 Million). Check total reinvestment intensity of LAVIPHARM S.A. NA EO 1 to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
LAVIPHARM S.A. NA EO 1 Financial Flexibility Index (2021–2024)
Historical Financial Flexibility Index trend for LAVIPHARM S.A. NA EO 1 across 4 annual periods. For the full cash flow conversion analysis, see LAVIPHARM S.A. NA EO 1 (BXA0) cash flow conversion.
Annual Financial Flexibility Index for LAVIPHARM S.A. NA EO 1 (2021–2024)
Year-by-year free cash flow to debt coverage for LAVIPHARM S.A. NA EO 1. Explore BXA0 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.20x | €14.28 Million | €4.64 Million | €72.52 Million | ▲ +227.4% |
| 2023 | 0.06x | €4.33 Million | €284.00K | €72.02 Million | ▼ -88.6% |
| 2022 | 0.53x | €38.96 Million | €3.35 Million | €73.86 Million | ▲ +448.7% |
| 2021 | 0.10x | €6.03 Million | €4.11 Million | €62.68 Million | — |